☆ 4.7 Article

Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics

BIOMOLECULES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Radiology, Nuclear Medicine & Medical Imaging

Lu-177-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer

Thorsten Derlin et al.

Summary: The study aimed to evaluate the feasibility, additional benefit, and toxicity of extending prostate-specific membrane antigen (PSMA) targeted radioligand therapy in patients with metastatic castration-resistant prostate cancer. The results showed that extending the treatment could achieve additional therapeutic effect with mild toxicity. Therefore, treatment extension is feasible and effective for patients with metastatic castration-resistant prostate cancer.

JOURNAL OF NUCLEAR MEDICINE (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity

Eline A. M. Ruigrok et al.

Summary: This study investigated the radiotoxic effects of [Lu-177]Lu-NeoB and its impact on target organs. The kidneys were found to be the most significantly affected organ. Histological and blood analyses revealed kidney damage and altered biochemical markers.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

Radiolabeled Bombesin Analogs

Rosalba Mansi et al.

Summary: Recent medical advancements have focused on personalized medicine, with nuclear medicine methodologies playing an important role. Using smart peptide carriers, such as analogs of the amphibian 14-peptide bombesin (BBN), clinically attractive radionuclides can be delivered to malignant lesions to minimize damage to healthy tissues.

CANCERS (2021)

添加到收藏夹

Article Oncology

[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes

Berthold A. Nock et al.

Summary: The study introduced [Tc-99m]Tc-DB15 as a novel diagnostic tool for GRPR-positive tumors using SPECT/CT, showcasing its high affinity to GRPR and good uptake properties in cell and animal models. In breast cancer patients, the tracer demonstrated the ability to effectively visualize multiple bone and soft tissue metastases.

CANCERS (2021)

添加到收藏夹

Article Oncology

Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?

Pinuccia Faviana et al.

Summary: The study found an inverse correlation between PSMA expression and GRPR expression, with the number of cells expressing GRPR showing a significant relationship with Gleason score, and trends in both the percentage of area expressing GRPR and the number of cells expressing PSMA. MDS analysis demonstrated that GRPR and PSMA represent inversely correlated measures of the same dimension.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Review Chemistry, Medicinal

[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer

Ute Hennrich et al.

Summary: Radiotracers targeting prostate-specific membrane antigen (PSMA) are commonly used for PET imaging of prostate cancer, with the recent approval of [Ga-68]Ga-PSMA-11 by the FDA in 2020. This radiopharmaceutical combines a peptidomimetic compound with the radionuclide Ga-68, allowing specific imaging of PSMA-positive tumor cells and potential applications in therapy planning and treatment response evaluation.

PHARMACEUTICALS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [99mTc]Tc-DB4 and [111In]In-SG4 in Mice Treated with Entresto

Panagiotis Kanellopoulos et al.

PHARMACEUTICS (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Synthesis and Evaluation of 68Ga- and 177Lu-Labeled (R)- vs (S)-DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives

Ruiyue Zhao et al.

MOLECULAR PHARMACEUTICS (2020)

添加到收藏夹

Article Oncology

Neuroendocrine differentiation of prostate cancer leads to PSMA suppression

Martin K. Bakht et al.

ENDOCRINE-RELATED CANCER (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair

Emmanouil Lymperis et al.

MOLECULES (2019)

添加到收藏夹

Article Oncology

Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26

Bogdan Mitran et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

添加到收藏夹

Article Biochemical Research Methods

Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin

Emmanouil Lymperis et al.

BIOCONJUGATE CHEMISTRY (2018)

添加到收藏夹

Article Chemistry, Medicinal

New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation

Berthold A. Nock et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor

Surya Ayalasomayajula et al.

CLINICAL PHARMACOKINETICS (2017)

添加到收藏夹

Article Oncology

Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26

Bogdan Mitran et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2016)

添加到收藏夹

Article Endocrinology & Metabolism

Gastrin-Releasing Peptide Receptor (GRPr) Promotes EMT, Growth, and Invasion in Canine Prostate Cancer

Said M. Elshafae et al.

PROSTATE (2016)

添加到收藏夹

Article Medicine, Research & Experimental

In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies

Kristell L. S. Chatalic et al.

THERANOSTICS (2016)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

To Serve and Protect: Enzyme Inhibitors as Radiopeptide Escorts Promote Tumor Targeting

Berthold A. Nock et al.

JOURNAL OF NUCLEAR MEDICINE (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Detecting ligand interactions with G protein-coupled receptors in real-time on living cells

Bo Xu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

添加到收藏夹

Article Endocrinology & Metabolism

Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates

Marc Beer et al.

PROSTATE (2012)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention

Erik Vegt et al.

JOURNAL OF NUCLEAR MEDICINE (2010)

添加到收藏夹

Article Biochemical Research Methods

In Vitro and in Vivo Metabolism of Lu-AMBA, a GRP-Receptor Binding Compound, and the Synthesis and Characterization of Its Metabolites

Karen E. Linder et al.

BIOCONJUGATE CHEMISTRY (2009)

添加到收藏夹

Article Oncology

Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides

Rosalba Mansi et al.

CLINICAL CANCER RESEARCH (2009)

添加到收藏夹

Article Endocrinology & Metabolism

Expression of the Gastrin-Releasing Peptide Receptor, the Prostate Stem Cell Antigen and the Prostate-Specific Membrane Antigen in Lymph Node and Bone Metastases of Prostate Cancer

Hildo J. K. Ananias et al.

PROSTATE (2009)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Bombesin receptor antagonists may be preferable to agonists for tumor targeting

Renzo Cescato et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

添加到收藏夹

Review Gastroenterology & Hepatology

Gastric secretion

ML Schubert

CURRENT OPINION IN GASTROENTEROLOGY (2002)

添加到收藏夹

Article Gastroenterology & Hepatology

Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist

P Hildebrand et al.

GUT (2001)

添加到收藏夹

Article Genetics & Heredity

The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter

DM Xiao et al.

GENE (2001)

添加到收藏夹

Article Gastroenterology & Hepatology

Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit

LP Degen et al.

GASTROENTEROLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.